USA — Navy Seeks Advances in Biomedical Research

WASHINGTON — Navy researchers are sup­port­ing today’s warfight­er with new advances in bio­med­ical research and devel­op­ment.

“Med­ical research and devel­op­ment activ­i­ty pro­vides the inspi­ra­tion for dis­cov­ery and fur­ther devel­op­ment of new ideas, new con­cepts, new drugs or sur­gi­cal inter­ven­tions,” Dr. Way­man Cheatham, spe­cial assis­tant for med­ical research to the Navy sur­geon gen­er­al and direc­tor of the Navy Bureau of Med­i­cine and Surgery’s Navy Med­i­cine Research and Devel­op­ment Cen­ter, said dur­ing a “DOD Live” blog­gers round­table yesterday. 

Cheatham said Navy Sur­geon Gen­er­al Vice Adm. (Dr.) Adam M. Robin­son Jr. has estab­lished five areas of pri­or­i­ty in terms of strate­gic research to sup­port the Defense Depart­ment as a whole as well as those under the care of Navy Health. Those pri­or­i­ties are trau­mat­ic brain injury and psy­cho­log­i­cal health, med­ical sys­tem sup­port for mar­itime and expe­di­tionary oper­a­tions, wound and injury man­age­ment through­out the con­tin­u­um of care, hear­ing restora­tion and pro­tec­tion and under­sea medicine. 

This over­all research the Navy does to sup­port these areas include sur­veil­lance for emerg­ing dis­ease, drug and vac­cine devel­op­ment, research­ing envi­ron­men­tal tox­ins, and med­ical research and devel­op­ment sup­port­ing force pro­tec­tion. To sup­port these efforts, the Navy has med­ical research and clin­i­cal inves­ti­ga­tion oper­a­tions on five con­ti­nents, as well as among the islands of the Pacif­ic Ocean. 

Cheatham said one of the Navy’s lat­est devel­op­ments in research has been try­ing to deter­mine the best agent to stop bleed­ing in peo­ple wound­ed on the bat­tle­field. Through a col­lab­o­ra­tive effort with the Army, researchers devel­oped Quik­Clot com­bat gauze, a wrap for wounds that seems to be more effec­tive in con­trol­ling bleeding. 

He said the lat­est tech­nolo­gies in wound and injury man­age­ment are pro­vid­ing the great­est degree of sur­vival and return of indi­vid­u­als to func­tion­al­i­ty fol­low­ing injury in any conflict. 

“Greater than 95 per­cent of indi­vid­u­als now who are injured on the bat­tle­field, when reached and found to be alive, sur­vive their injuries through a long con­tin­u­um of care,” he said, call­ing that sur­vival rate “astound­ing and historical.” 

The Navy also is research­ing the use of hyper­bar­ic oxy­gen cham­bers in treat­ing trau­mat­ic brain injury and post-trau­mat­ic stress, he said. 

“We have been involved in a num­ber of very sig­nif­i­cant research projects,” he added. “It’s impor­tant that the ques­tion of hyper­bar­ic oxy­gen uti­liza­tion for treat­ment of trau­mat­ic brain injury or post-trau­mat­ic stress dis­or­der be inves­ti­gat­ed in a very, very rig­or­ous and eth­i­cal fashion.” 

Mon­i­tor­ing the long-term effects of ser­vice on sub­marines to deter­mine whether unan­tic­i­pat­ed sit­u­a­tions devel­op or health con­cerns emerge is anoth­er area of ongo­ing research, Cheatham said, and Navy researchers also are work­ing with agen­cies such as the Cen­ters for Dis­ease Con­trol and the World Health Orga­ni­za­tion in vac­cine development. 

“Navy lab­o­ra­to­ries have been inte­gral to the process of inves­ti­ga­tion and vac­cine devel­op­ment by means of their being deployed around the world,” he said. “They have an oppor­tu­ni­ty to actu­al­ly be first on hand to sam­ple out­breaks of infec­tion or ill­ness and deter­mine the actu­al type of virus that might be involved. So Navy serves as a very, very impor­tant link in the world­wide sur­veil­lance and inter­ven­tion process.” 

Cit­ing con­cerns about using resources to the fullest extent pos­si­ble, Cheatham said he can assure the pub­lic that the Navy is car­ry­ing out its com­mit­ment to the high­est cal­iber of research and med­ical edu­ca­tion, and that those two areas are being main­tained as strate­gic pri­or­i­ties for the Navy. 

“New link­ages between research and devel­op­ment and our clin­i­cal activ­i­ties at our med­ical treat­ment facil­i­ties are evi­dence of this type of com­mit­ment,” he said. 

Source:
U.S. Depart­ment of Defense
Office of the Assis­tant Sec­re­tary of Defense (Pub­lic Affairs) 

More news and arti­cles can be found on Face­book and Twitter.

Fol­low GlobalDefence.net on Face­book and/or on Twit­ter

Team GlobDef

Team GlobDef

Seit 2001 ist GlobalDefence.net im Internet unterwegs, um mit eigenen Analysen, interessanten Kooperationen und umfassenden Informationen für einen spannenden Überblick der Weltlage zu sorgen. GlobalDefenc.net war dabei die erste deutschsprachige Internetseite, die mit dem Schwerpunkt Sicherheitspolitik außerhalb von Hochschulen oder Instituten aufgetreten ist.

Alle Beiträge ansehen von Team GlobDef →